• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Waystar Holding (WAY) A Bargain On Raised Q2 Guidance And Larger Client Wins?

    Simply Wall St·08/09/2026 08:29:06
    Listen to the news

    Waystar Holding stock reacts to stronger Q2 update and outlook

    Waystar Holding (WAY) has been in focus after reporting Q2 2026 results that highlighted stronger revenue and earnings, supported by demand for its AI powered healthcare payments platform and larger client wins.

    The company also raised full year 2026 revenue and adjusted EBITDA guidance and outlined several large health system contracts. These updates, alongside recent share repurchases, give investors fresh data points to reassess the stock.

    See our latest analysis for Waystar Holding.

    Waystar Holding’s recent Q2 guidance raise, buyback activity and CFO transition have come alongside a 90 day share price return of 13.33% and a year to date share price decline of 22.76%, with the 1 year total shareholder return down 29.95%. This points to near term momentum but a weaker longer term record.

    If the Q2 rebound has you looking beyond a single stock, this is a good moment to see what else is moving across healthcare technology. You can review a curated group of AI driven healthcare stocks via the Simply Wall St screener here 43 healthcare AI stocks

    Bulls point to Waystar Holding’s AI driven growth, stronger guidance and buybacks. Bears focus on the share price slide since listing and the CFO change. Which of those stories does the current valuation really support?

    Most Popular Narrative: 28.4% Undervalued

    Waystar Holding’s most followed narrative pegs fair value at $33.83 per share, versus the latest close at $24.23. That gap sits at the center of the current debate.

    The acquisition of Iodine Software, a leading provider of AI-powered clinical intelligence, will expand Waystar's total addressable market by over 15%, accelerate its product roadmap, and immediately boost gross margins and adjusted EBITDA margins, setting up compounding, long-term revenue and earnings growth.

    Read the complete narrative.

    Want to see what really sits behind that fair value for Waystar Holding? The narrative leans heavily on sustained revenue compounding, rising margins, and a richer earnings multiple that assumes the market will pay up for that profile.

    Result: Fair Value of $33.83 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, the story for Waystar Holding can change quickly if the Iodine acquisition adds more financial strain than value, or if major clients push harder on pricing.

    Find out about the key risks to this Waystar Holding narrative.

    Next Steps

    The debate around Waystar Holding is clearly split, so this is a good moment to move fast and test the numbers yourself. Start by reviewing the 4 key rewards.

    Looking for more Waystar Holding style investment ideas?

    If Waystar Holding has sharpened your focus, do not stop here. Fresh ideas often appear where you least expect them, and missing them can cost you opportunities.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.